Ran-GTPase regulates multiple cellular processes such as nucleocytoplasmic transport, mitotic spindle assembly, nuclear envelope assembly, cell-cycle progression and the mitotic checkpoint. The leishmanial Ran protein, in contrast with its mammalian counterpart which is predominately nucleoplasmic, is localized at the nuclear rim. The aim of the present study was to characterize the LdRan (Leishmania donovani Ran) orthologue with an emphasis on the Ran-histone association. LdRan was found to be developmentally regulated, expressed 3-fold less in the amastigote stage. LdRan overexpression caused a growth defect linked to a delayed S-phase progression in promastigotes as for its mammalian counterpart. We report for the first time that Ran interacts with a linker histone, histone H1, in vitro and that the two proteins co-localize at the parasite nuclear rim. Interaction of Ran with core histones H3 and H4, creating in metazoans a chromosomal Ran-GTP gradient important for mitotic spindle assembly, is speculative in Leishmania spp., not only because this parasite undergoes a closed mitosis, but also because the main localization of LdRan is different from that of core histone H3. Interaction of Ran with the leishmanial linker histone H1 (LeishH1) suggests that this association maybe involved in modulation of pathways other than those documented for the metazoan Ran-core histone association.
INTRODUCTION
Ran-GTPase, or Ran, belongs to the Ras superfamily of monomeric G-proteins that switches between a GDP-and a GTPbound form [1] . The transition from Ran-GDP to Ran-GTP occurs only by nucleotide exchange. The nucleotide-exchange factor RCC1 (regulator of chromosome condensation 1) catalyses this reaction and results in efficient generation of nuclear Ran-GTP [2] . The conversion of Ran-GTP into Ran-GDP is catalysed in the cytosol by Ran-GAP1, which activates Ran's intrinsic GTPase activity [3] . Ran is involved in multiple cellular processes such as modulation of nucleocytoplasmic transport of macromolecules across the nuclear envelope [4] , mitotic spindle assembly [5] , postmitotic nuclear envelope assembly [6] , cell-cycle progression [7] and the mitotic checkpoint [8] .
The predominant localization of Ran in most eukaryotic cells is in the nucleoplasm, where it is found mostly in the GTP-bound form [7] . The Ran-GTP gradient across the interphase nuclear envelope and on the condensed mitotic chromosomes is essential for many cellular processes, including nucleocytoplasmic transport and spindle assembly [9] . The mammalian Ran is known to interact in the nucleoplasm with chromatin. This interaction occurs via two distinct mechanisms. One mechanism is the interaction of Ran with its nucleotideexchange factor RCC1 which in turn interacts with histones H2A and H2B [10] and the other via a direct binding of Ran to histone H3 and histone H4 [11] . The Ran-RCC1 binary complex binds stably to chromatin and ensures that RCC1 couples its GEF (guanine-nucleotide-exchange factor) activity to chromosome binding [12] . Via these core histone-Ran and core histone-Ran-RCC1 interactions, at least in animal cells, Ran-GTP appears to form during mitosis a gradient with the highest concentration on the condensed chromosomes that tapers off towards the periphery of the cell [12] . Experiments in Xenopus egg extracts suggest further that a high Ran-GTP concentration near the chromosomes stimulates microtubule nucleation, whereas microtubule stabilization is favoured by the lower concentration of Ran-GTP found further away from the chromosomes [13] . These differential effects of Ran-GTP on microtubules could be critical for spindle assembly. Taken together, these findings indicate that the mitotic Ran-GTP chromosomal concentration gradient is important to navigate spindle assembly towards the condensed RCC1-rich chromosomes in animal cells.
The Ran-GTP chromosomal gradient is not so evident in systems where Ran is not predominantly nucleoplasmic. Only a few examples of non-nucleoplasmic localization of Ran are known to date. One such example is the localization of the Ran2 protein of Arabidopsis, a plant orthologue of Ran localized in the nuclear envelope/rim and in perinuclear structures [14] . Another example is Toxoplasma gondii's Ran orthologue, which was detected throughout the cell [15] . Additionally the trypanosomatid LmjRan (Leishmania major Ran) fused to GFP (green fluorescent protein) was recently found to decorate a nuclear envelope 'collar' and to be closely associated with nuclear pore complexes [16] .
Leishmania is a protozoan parasite, a member of the Trypanosomatidae family, which is responsible for a spectrum of diseases in humans. Depending on the Leishmania species and on the immunological response of the host, the disease ranges from self-healing skin lesions to life-threatening visceral leishmaniasis, causing extensive morbidity and mortality [17] . Worldwide, 14 million people are infected with Leishmania, with an estimated yearly incidence of 1.5-2 million new cases [17] . Leishmania is transmitted by the blood-sucking phlebotomine sandfly. During its life cycle, the parasite exists in two forms: as an extracellular flagellated promastigote in the insect vector, and in the non-motile amastigote form in the acidic phagolysosome of the macrophage in the mammalian host [18] . Recent advances in parasite differentiation and survival strategies within the macrophages have facilitated the understanding of key aspects of Leishmania pathogenesis, although many more remain unknown (reviewed in [19] ).
The fundamental processes of cell biology mediated by Ran are expected to play a crucial role in survival and growth strategies of the Trypanosomatid parasites. A Ran orthologue in Trypanosoma brucei, rtb2 [20] , has been shown to be an essential gene for parasite survival [16] . The L. major orthologue was identified recently and was shown to co-localize at the nuclear membrane with the homologue of nucleoporin Sec13 [16] . Several potential partners of LmjRan have been identified by BLAST search [NTF2 (nuclear factor 2), CAS (cellular apoptosis susceptibility), RanBP1 (Ran-binding protein 1)], and their localization matches the nuclear envelope localization of LmjRan [16] .
The present paper describes the investigation of an interaction of LdRan (Leishmania donovani Ran) orthologue with the leishmanial histones H1, H2B and H3 (LeishH1, LeishH2B and LeishH3 respectively). LdRan was found to interact specifically with LeishH1 and co-localize with this histone at the nuclear rim. This is the first evidence of an interaction of a Ran protein with a linker histone, opening the field to a more in-depth investigation on the purpose of this interaction to the parasite's cell biology.
EXPERIMENTAL

Plasmids
The gene encoding LdRan (GenBank ® accession number EU426549) was amplified by PCR, from genomic L. donovani (MHOM/ET/0000/HUSSEN) DNA. The forward and reverse primers used were 5 -TTTTGGAATTCTATGCAACAGGCACC-CTCG-3 and 5 -ATGGGCGATGACGAGGGACTCGAGGCCG-3 respectively, based on the Leishmania infantum DNA sequence. The PCR product was cloned in the EcoRI and XhoI site of the pTriex1.1 (Novagen), in-frame with the C-terminal His 6 tag to generate the pTriex-LdRan plasmid.
For the generation of a leishmanial LdRan expression plasmid, the LdRan-encoding DNA was amplified from genomic L. donovani (MHOM/ET/0000/HUSSEN) DNA by using as forward and reverse primers 5 -GCACGGATCCGTACACCATGCAAC-AGGCACC-3 and 5 -GACACTCGAGGGGTCTCACTCGTCA-TC-3 respectively. The PCR product was then digested with BamHI and XhoI and inserted in the BglII and XhoI site of the LEXSY-SAT vector, to generate the LdRan-SAT plasmid.
Murine Rab1a (GenBank ® accession number AF226873) cDNA was amplified by RT (reverse transcription)-PCR using the forward and reverse primers, 5 -CGCGGATCCATGTCCAGCA-TGAATCCCG-3 and 5 -ATAAGAATGCGGCCGCTTAGCAG-CAGCC-3 respectively. The amplified product was cloned in the BamHI and NotI restriction sites of pGEX4T1 plasmid as a fusion protein with GST (glutathione transferase).
The LeishH1 gene was cloned in pGEX-4T1 as described previously [21] . The INO1 (myo-inositol-1-phosphate synthase) gene was cloned in the pTriex1.1 plasmid as described previously [22] .
Cell culture and transfection
L. donovani (MHOM/ET/0000/HUSSEN) promastigotes were cultured in Medium 199 containing 10 % (v/v) HIFBS (heatinactivated fetal bovine serum) at 26
• C as described previously [21] . L. donovani parasites were transfected with the Leishmania SAT expression plasmid (supercoiled, transfected as episomes), LdRan-SAT, as described previously [21] . For selection of transgenic parasites, 100 μg/ml noursethricin (Jena Bioscience) was used. To assess the growth of these parasites, parasites were immobilized by the addition of 30 μl of 3.7 % (w/v) formaldehyde in 1 ml of PBS, and counted in a Malassez haemocytometer.
Axenic L. donovani amastigotes were generated as described previously [21] .
SDS/PAGE and immunoblotting
SDS/PAGE was performed using the method of Laemmli [23] . For immunoblotting, proteins were transferred on to a nitrocellulose filter (Hybond C, GE Healthcare) and immunoblotting was performed as described previously with the use of 3,3 -diaminobenzidine as a chromometric substrate [24] or by ECL ® Plus (enhanced chemiluminescence) (GE Healthcare) according to the manufacturer's instructions. For the quantification of immunoblot bands, AlphaImager software (Alpha Innotech) was used.
Production of recombinant proteins and generation of antibodies
Recombinant LdRan and LinINO1 (L. infantum INO1) were generated as C-terminal His 6 -tagged proteins in the Escherichia coli strain BL21 pLysS, as described previously [21] and the recombinant proteins were purified on a Ni-NTA (Ni 2+ -nitrilotriacetate) matrix under denaturing conditions according to the manufacturer's instructions (Qiagen).
Loads of 300 μg (LdRan and INO1) and 30 μg (LeishH2B and LeishH3 [25] and LdRan) of recombinant proteins were used per injection for the immunization of two New Zealand white rabbits and two Balb/c mice respectively for each protein, as described previously [21] . All procedures involving animals were conducted in accordance with the European Guidelines, approved by the ethical committee of the Hellenic Parleur Institute. Affinity-purified Abs (antibodies) (anti-LdRan, antiLeishH1, anti-LeishH2B and anti-LeishH3) were isolated by low-pH elution from nitrocellulose strips with purified LdRan, LeishH1, LeishH2B and LeishH3 respectively, as described previously [21] . A second step of affinity-purification of the antiLdRan Ab, was followed to ensure its specificity.
Immunofluorescence
L. donovani promastigotes (3-5×10 6 /ml) were washed once with PBS and then fixed for 20 min at room temperature (25
• C) with PBS containing 2 % (w/v) paraformaldehyde or with ice-cold methanol for 5 min. The parasite cells were then permeabilized and blocked by incubation for 1 h at room temperature with blocking buffer (0.3 % BSA and 0.1 % Triton X-100 in PBS) and were subsequently stained with the affinitypurified anti-LdRan Ab (0.2 μg/ml) diluted in blocking buffer. For co-localization studies, affinity-purified rabbit anti-LeishH1 [21] , mouse anti-LeishH2B, anti-LeishH3 and anti-LdRan pAbs (polyclonal Abs) were used at concentrations of 2-10 μg/ml. The commercially available mAb (monoclonal Ab) specific for nuclear pore complex proteins that recognizes the conserved FXFG repeats in nucleoporins (Abcam) was used at a final concentration of 10 μg/ml. Incubation with the primary Abs, was performed overnight in a humid chamber at 4
• C. After extensive washing, the appropriate secondary Abs were added, Alexa Fluor ® 546-and Alexa Fluor ® 488-conjugated anti-rabbit and anti-mouse (Molecular Probes), at a final concentration of 2 μg/ml in blocking buffer, for 2 h at room temperature. The secondary Ab was removed with extensive washing and the parasite DNA was stained for 10 min at room temperature with 10 μg/ml PI (propidium iodide) solution in PBS containing 100 μg/ml RNase. Samples were washed twice with PBS and the coverslips were mounted with Mowiol. Microscopic analysis of the samples was performed by a Leica TCS SP confocal microscope using the 63× apochromat lens.
For quantifying co-localization of LdRan with LeishH1, the Pearson's correlation coefficient (r) and the red/green and green/red pixel correlation, were calculated by the Intensity Correlation Analysis program ImagePro 5 software (Media Cybernetics) from a typical image out of at least 15 cells from three independent experiments.
Cell synchronization and flow cytometry
L. donovani parasites in the exponential phase (∼ 5×10 6 /ml) were synchronized with 5 mM HU (hydroxyurea) in the G 1 /S-phase border of the cell cycle, as described previously [21] . PI labelling and flow cytometry (FACS) analysis in a FACSCalibur flow cytometer (Becton-Dickinson Immunocytometer System) were performed as described previously [21] .
LdRan and GST-LeishH1 pull-down assays
LdRan was purified under denaturing conditions (6 M urea), as described above, and maintained bound to the Ni-NTA beads (∼ 2 μg of LdRan per reaction). The urea was removed by washing the beads five times with 10 bed volumes of PBS (pH 8). The beads were finally resuspended in 1 ml of leishmanial protein extract (2 mg/ml) in PBS (pH 8), containing 5 mM MgCl 2 , 1 mM PMSF, 2.5 μg/ml aprotinin and 1 μg/ml pepstatin. As a control, 2 μg of GST or GST-Rab1a was immobilized on glutathione-Sepharose 4B beads (GE Healthcare) and incubated with 1 ml of parasite protein extract (2 mg/ml). The binding reaction was performed at room temperature for 3 h. Subsequently, unbound proteins were removed by centrifugation at 1000 g for 5 min and the beads were washed four times with 10 volumes of PBS (pH 8). Finally, proteins bound to the beads were eluted with an equal volume of elution buffer (50 mM sodium phosphate buffer, pH 8, 300 mM NaCl and 250 mM imidazole) three times.
For the GST-LeishH1 pull-down assays, 2 μg of GST and GST-LeishH1 [21] were immobilized on 50 μl of glutathioneSepharose 4B beads according to the manufacturer's instructions and incubated for 3 h at room temperature with 1 ml of leishmanial protein extract (2 mg/ml) in PBS containing 5 mM MgCl 2 , 1% (v/v) Triton X-100, 1 mM PMSF, 2.5 μg/ml aprotinin and 1 μg/ml pepstatin. Glutathione-Sepharose beads were subsequently washed four times with 20 volumes of PBS containing 5 mM MgCl 2 and 1 % (v/v) Triton X-100 and then frozen at − 20
• C before their analysis by SDS/PAGE and Western blotting.
RESULTS
Identification and characterization of LdRan; LdRan is developmentally regulated
An ORF (open reading frame) encoding a putative leishmanial Ran orthologue was identified (LinJ25.1470) as a single locus on To detect LdRan, anti-LdRan Ab was used (LdRan). An anti-LinINO1 Ab (INO1) was used to confirm that equal amounts of parasite extracts were loaded in both lanes. The experiment was performed at least three times. The intensities of the bands were analysed using AlphaImager Software. The fold overexpression was calculated by dividing the band intensity of LdRan with the band intensity of INO1 and comparing this ratio in LdRanSAT-transfected parasites over the same ratio in control SAT parasites. Molecular masses are indicated in kDa.
chromosome 25, in the L. infantum genome after a search in the Leishmania GeneDB database. Primers based on the L. infantum LinJ25.1470 ORF were designed and the putative LdRan gene was amplified and cloned in the bacterial expression plasmid pTriex with a C-terminal His 6 tag.
The putative LdRan protein (GenBank ® accession number EU426549), was identical with the LinRan (L. infantum Ran) and LmjRan orthologues. Amino acid sequence alignment of LdRan with Ran proteins from different species showed that it is highly conserved, having 80 % amino acid sequence identity with Ran orthologues from species as distant as Homo sapiens. Western blot analysis using the generated anti-LdRan Ab showed that LdRan is expressed in L. donovani promastigotes as a ∼ 25 kDa protein, in agreement with the predicted molecular mass (24223 Da) ( Figure 1A) .
LdRan expression was also evaluated in axenic amastigotes [21] by Western blot analysis using the LdRan-specific Ab ( Figure 1A ) and by immunofluorescence (results not shown). Scanning densitometry of the detected bands revealed that the LdRan expression level was 3-fold lower in amastigotes. As a Values are from one representative experiment performed four times. All four experiments showed a consistent 8-12 % difference between the control SAT parasite population and the LdRan-SAT population found in the S-and G 2 /M-phases 6 and 10 h after HU release.*P < 0.05 compared with corresponding control values (SAT), using a two-tailed paired Student's t test.
Proportion of SAT parasite
Proportion of LdRan-SAT parasite population (%) population (%) control for loading an equal number of cells, the blot was probed with LinINO1 antiserum, a 46 kDa protein which is equally expressed in promastigotes and amastigotes [26] ( Figure 1A , panel 1). Expression of A2 proteins was also checked with the anti-A2 C9 mAb to ensure that axenic amastigotes had properly differentiated and expressed amastigote-specific proteins as expected ( Figure 1A , panel 2).
Overexpression of LdRan delays cell-cycle progression in Leishmania
LdRan was overexpressed by stable transfection of L. donovani parasites with an episomal plasmid. Parasites were viable with no apparent morphological differences from control parasites (bearing plasmid alone, SAT). Overexpression of LdRan, in the LdRan-SAT parasites compared with control parasites, was assessed by Western blot analysis and quantification by densitometry which showed a 3-fold ( Figure 1B ) overexpression. Equal loading was confirmed with the use of an anti-INO1 Ab as a loading control ( Figure 1B) . The growth curve of these promastigotes indicated a mild but consistent delay in the exponential phase of their growth (see Supplementary Figure S1A at http://www.BiochemJ.org/ bj/424/bj4240367add.htm), suggesting that LdRan overexpression delays cell division. This effect was more pronounced upon host-free differentiation conditions (see Supplementary Figure  S1B ). Annexin V-PI staining showed that there was no significant difference in early apoptotic and necrotic (or late apoptotic) control and LdRan-overexpressing parasites (results not shown). This confirms that the effect is solely due to a delay in growth and not due to increased cell death.
To determine which phase of the cell cycle is affected by LdRan overexpression we evaluated, using flow cytometry, the cellcycle progression of L. donovani promastigotes overexpressing LdRan (LdRan-SAT) and compared it with cell-cycle profiles of control parasites (SAT). SAT and LdRan-SAT L. donovani exponential-phase parasites were synchronized in the G 1 /Sphase of the cell cycle with HU ( Figure 2 and Table 1 ). Both SAT and LdRan-SAT HU-synchronized parasites had a greater percentage of cells in the G 0 /G 1 -phase of the cell cycle (72 and 71 % respectively) compared with the G 0 /G 1 -phase of the same asynchronous exponential-phase parasites (55 and 52 % respectively), as expected. At 4 h after release, more parasites overexpressing LdRan were in the G 1 /S-phase border (35 %) compared with control parasites (27 %, Figure 2 and Table 1) . At 6 h after release, 31 and 50 % of control parasites were in the S-and G 2 /M-phases of the cell cycle, whereas 41 and 33 % of LdRan-overexpressing parasites were in the S-and G 2 /M-phases respectively ( Figure 2 and Table 1 ). Therefore LdRan-overexpressing parasites show a delay in the completion of S-phase. At 10 h after release, there was still a greater percentage of LdRan-overexpressing parasites in the S-phase, compared with control (30 and 18 % respectively), confirming that LdRan overexpression causes a constant deregulation of Sphase progression (confirmed in all experiments). This delay in the phases of the cell cycle was calculated to be approx. 2 h with respect to the control parasites, a duration that is significant at the promastigote stage, where the parasite completes one cell cycle within 8-10 h. 
LdRan at the nuclear envelope co-localizes with linker histone H1
The localization of endogenous Ran in wild-type L. donovani promastigotes was assessed using an affinity-purified anti-LdRan primary Ab. Double staining with PI ( Figure 3A, row 1) or detection of FG (Phe-Gly) nucleoporins ( Figure 3A, row 2) showed that LdRan is localized at the nuclear envelope/rim, as is the case for LmjRan [16] , which, as mentioned above, is identical with LdRan. Quantititative analysis using the ImagePro software showed that 95 % of LdRan co-localizes with FG nucleoporins, whereas 70 % of FG nucleoporins co-localizes with LdRan ( Figure 3A, row 2) . Expression of LmjRan as a fusion protein with GFP [16] , cloned in the plasmid pTH 6 cGFPn vector [27] , in L. donovani showed that that GFP-LmjRan is localized at the vicinity of the nuclear envelope (results not shown) confirming thereby the specificity of the generated anti-LdRan Ab used in immunostaining.
Since LdRan does not predominantly localize in the nucleoplasm of promastigotes we investigated whether LdRan associates with histones. First we examined the degree of core histone co-localization with LdRan. For this study we used histone H3, being one of Ran's binding proteins in mammalian cells. We also investigated LdRan's co-localization with LeishH1, knowing from previous studies that this histone had a nuclear rim localization at least in the majority of parasites (D. Smirlis and K. Soteriadou, unpublished work). For this purpose a rabbit anti-LdRan and a mouse anti-LeishH3 or a rabbit antiLeishH1 pAb and a mouse anti-LdRan pAb were used in double immunofluorescence staining experiments ( Figure 3B , rows 1 and 2 respectively). Figure 3 (B), row1 shows that LeishH3 is predominantly localized in the nucleoplasm of the parasite (in 70 % of the cells LeishH3 was nucleoplasmic, and in 30 % of the cells was closer to the nuclear rim), whereas nuclear LdRan although present in lower concentrations in the nucleoplasm, was predominantly found at the nuclear rim. LdRan and LeishH3 showed a moderate co-localization. Quantitative analysis using the ImagePro software showed that 40 % of LdRan co-localized with LeishH3 and 60 % of LeishH3 co-localized with LdRan. The Pearson correlation co-efficient indicating the strength and direction of a linear relationship between two random variables, was also moderate (r = 0.65). On the other hand, Figure 3 (B), row 3 shows that LeishH1 is localized near the nuclear periphery and close to the nuclear envelope. This localization of LeishH1 was not uniform, but was detected in the majority of cells. In more detail, in 75 % of parasites LeishH1 localized at the nuclear rim, where the linker histone did not co-localize with the bulk DNA, and in 25 % of the parasites, LeishH1 was nucleoplasmic. LdRan co-localizes at the nuclear rim, with LeishH1 ( Figure 3B, row 2) . More specifically, quantitative analysis showed that 90 % of LeishH1 co-localized with LdRan and 80 % of LdRan co-localized with LeishH1, with r = 0.9. The co-localization of LdRan with LeishH1 is significant, taking into account the dynamic nature of Ran and histone H1 proteins [28, 29] . This co-localization was found to be independent of the fixation method, and shows clearly that linker histone H1 may be a candidate partner of LdRan.
LdRan interacts in vitro with linker histone LeishH1
To investigate a possible interaction of LdRan with linker histone H1, we performed LdRan pull-down experiments. We examined in parallel the interaction of LdRan with LeishH3, expecting that these proteins interact in vitro since the mammalian histone H3 globular domain responsible for binding to Ran [11] is well conserved in Leishmania [30] . We also assessed the binding of LeishH2B to LdRan as a negative control, since the mammalian histone H2B is not known to interact directly with Ran, but via RCC1 [10] . As shown in Figure 4 (A) LdRan interacts with LeishH1 and LeishH3, but it does not interact with LeishH2B.
The anti-histone Abs detected histones almost equally well in equally loaded protein inputs used for the binding reactions ( Figure 4A ). LeishH1 bound equally well to LdRan as to LeishH3 in vitro. Additionally, to verify that LdRan interacted directly with linker LeishH1, we incubated recombinant histone H1 (cleaved with thrombin from the GST moiety) with LdRan-bound Ni-NTA beads. LeishH1 was detected on the LdRan-Ni-NTA beads, whereas no LeishH1 was immobilized on an equal volume of Ni-NTA beads (results not shown), supporting the direct interaction between the two proteins.
To examine the specificity of the interaction of LdRan with LeishH1, we performed a pull-down assay using murine Rab1a, which is 30 % identical and 50 % homologous with LdRan. Rab1a was used as a GST-fusion protein, and equal amounts of GST, GST-Rab1a and LdRan were immobilized on glutathioneSepharose and Ni-NTA beads respectively ( Figure 4B , panel B1). LeishH1 was only detected in beads with immobilized LdRan ( Figure 4B, panel B2) .
To eliminate the possibility that the in vitro interaction of LdRan with LeishH1 was due to an 'aberrant' refolding of recombinant LdRan, equal amounts of GST (used as a negative control) and GST-LeishH1 were immobilized on glutathione-Sepharose beads ( Figure 4C ) and incubated with leishmanial protein extracts. Additionally, equal amounts of GST and GST-LeishH1 that were not incubated with leishmanial extracts were also used as negative controls ( Figure 4C ). Beads were washed extensively after the completion of the incubation period. Native LdRan was present only in GST-LeishH1 and not in GST-bound beads ( Figure 4C ), indicating that LdRan interacts specifically with LeishH1. Therefore denaturation and refolding of recombinant LdRan had no effect on the ability of this protein to interact with LeishH1.
DISCUSSION
The aim of the present study was to characterize the Ran orthologue from L. donovani, emphasizing its interaction with histones. The 3-fold down-regulation of LdRan in axenic amastigotes was in agreement with results from previous studies showing that the mRNA encoding the leishmanial Ran was down-regulated in amastigotes by a factor of 2.3 compared with the promastigote stage [31] and that the LdRan protein expression level decreased during differentiation [32] . In the amastigote stage, the parasites undergo a number of changes including morphological ones, deregulation of cellcycle progression and a decrease in the rate of protein synthesis [33] . Therefore down-regulation of expression in the amastigote stage of a protein involved in essential cellular functions such as regulation of cellular division, cell-cycle progression and nucleocytoplasmic traffic is not an unexpected finding. Overexpression of LdRan significantly affected the division of parasites during differentiation, suggesting that LdRan downregulation is required for appropriate promastigote to amastigote differentiation.
L. donovani promastigotes tolerated overexpression of LdRan, but these parasites also had a growth defect, linked with the delay in S-phase progression. In mammalian cells, expression of mutants stabilizing Ran in its GTP-bound form [34] or depletion of RCC1 [35] (which results in the enrichment of the GDP-bound form of Ran) both cause a delay in cell-cycle progression, indicating that any disturbance in the GTP/GDPbound state of Ran may bring deregulation in S-phase progression [36] . Importin-β appears to be dispensable for regulating cellcycle progression [37] , but more investigations are required for revealing the precise mechanism by which Ran modulates cellcycle progression.
LdRan, like LmjRan [16] , localizes at the nuclear rim where it co-localizes with FG nucleoporins. Interestingly, LdRan expressed in mammalian cells (COS7), localizes at the nucleoplasm (results not shown) indicating that the nuclear rim localization of LdRan is due to parasite-specific interacting proteins. Some of these proteins could be proteins in the Ran network, such as NTF-2 and CAS, and present in the leishmanial nuclear envelope [16] .
In metazoan cells, Ran interacts in the nucleoplasm with histones and this interaction occurs via two distinct mechanisms: one being a direct interaction of Ran with core histones H3 and H4 [11] , and the other being its indirect interaction with the other two core histones H2A and H2B via RCC1 [10] . The nuclear rim predominant localization of LdRan in L. donovani promastigotes raised the question of whether an LdRan-histone association occurred. LdRan as its mammalian counterpart was able to bind to histone H3, but not to histone H2B in vitro. Core histones in Leishmania, however, are present predominately in the nucleoplasm in contrast with the LdRan localization at the nuclear periphery. Therefore the moderate co-localization of LdRan with LeishH3 makes their interaction in vivo still speculative. In contrast, LeishH1 was present at the nuclear rim in the majority of cells by at least two methods of cell fixation (results not shown). LdRan and LeishH1 directly interacted in vitro and co-localized at the nuclear rim. This is the first evidence to date of a linker histone interacting with Ran. It is not currently known whether this interaction is unique for Leishmania spp., or whether it exists in other organisms. It is known that Ran [14] and histone H1 in plants are both present at the nuclear rim, away from the nucleoplasmic histone H3 [38] , but their interaction has not been investigated. Plant histone H1 possesses microtubule-organizing activity, forming ring-shaped complexes with tubulin at atypical MTOCs (microtubule-organizing centres) present in the nuclear periphery of plant cells [38, 39] . A possible explanation for the interaction of LdRan with LeishH1 at the nuclear periphery is its involvement in the organization and elongation of microtubules adjacent to the leishmanial nuclear envelope [40] .
Interaction of Ran with chromatin in metazoans has an unknown function in interphase cells. In mitotic cells, it is postulated that the Ran-histone association, required for the formation of a Ran-GTP chromosomal gradient, may play an important role during reassembly of the nuclear envelope by increasing the binding of membranes to the chromatin surface [11] and for the formation of the mitotic spindle [9] . In Leishmania, the nucleus does not break down during mitosis [40] , therefore the requirement of a Ran-GTP chromosomal gradient for the post-mitotic nuclear envelope assembly is clearly not required. It has been reported that, in the closed mitosis of Aspergillus nidulans, the nuclear pores open, allowing passive diffusion of proteins [41] . Thus the Ran-GTP chromosomal gradient may be essential, even in organisms performing a closed mitosis. Therefore one cannot exclude the possibility that the Ran-LeishH1 interaction in Leishmania is required to keep a form of an atypical chromosomal nuclear rim Ran-GTP gradient in the nuclear rim chromatin. However, the LdRan-linker histone H1 interaction may modulate pathways other than those documented for the metazoan Rancore histone association. In L. donovani, LeishH1 regulates cell-cycle progression, promastigote to amastigote differentiation and virulence [21] . Interaction of LdRan with LeishH1 may be important for the regulation of these processes.
Ran appears to be a master regulator and co-ordinator of events that require intimate cross-talk between chromatin and the cytoplasm, for cell-cycle progression and spindle assembly [42] . In Leishmania, these events have similarities, but also major differences from other eukaryotes such as metazoans and yeast. Further investigation is therefore required to elucidate these mechanisms and to define the precise mechanism of LdRan participation in the cell cycle of this parasite, and whether an atypical Ran-GTP chromosomal gradient is achieved. Finally, the atypical Ran network in this parasite may be exploited for antileishmanial drug development.
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